Dr. Marina Baretti, oncologist based in Baltimore, is dedicated to advancing translational research, particularly in the realm of gastrointestinal (GI) cancer care. Her expertise lies in bridging the gap between laboratory discoveries and patient care, collaborating closely with researchers to introduce innovative treatments to clinical practice.
At Johns Hopkins, Dr. Baretti has spearheaded a research program focused on hepatobiliary cancer. With a special emphasis on epigenetic therapies as immune sensitizers, she focuses on the treatment approaches in this challenging field.
Dr. Baretti’s academic journey began at the University of Pisa, Italy, where she earned her medical degree. She then pursued further training in Internal Medicine and Oncology at the University of Milan, followed by research and clinical fellowships at Johns Hopkins University School of Medicine. Since joining the faculty in 2021, she has been instrumental in driving forward the field of oncology.